427 related articles for article (PubMed ID: 10595592)
1. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
2. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
Hilz MJ; Marthol H; Neundörfer B
Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
Foster TS
Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
[TBL] [Abstract][Full Text] [Related]
6. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
Papanas N; Maltezos E
Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy.
Sachse G; Willms B
Horm Metab Res Suppl; 1980; 9():105-7. PubMed ID: 6769773
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic polyneuropathy: Update 2006.
Ziegler D
Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306
[TBL] [Abstract][Full Text] [Related]
9. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
[TBL] [Abstract][Full Text] [Related]
10. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
Vereşiu IA
Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diabetic neuropathy and neuropathic pain: how far have we come?
Ziegler D
Diabetes Care; 2008 Feb; 31 Suppl 2():S255-61. PubMed ID: 18227494
[TBL] [Abstract][Full Text] [Related]
12. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
[TBL] [Abstract][Full Text] [Related]
13. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
14. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
15. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
Ruessmann HJ;
J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
[TBL] [Abstract][Full Text] [Related]
16. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
Tang J; Wingerchuk DM; Crum BA; Rubin DI; Demaerschalk BM
Neurologist; 2007 May; 13(3):164-7. PubMed ID: 17495764
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
19. Painful diabetic neuropathy: treatment and future aspects.
Ziegler D
Diabetes Metab Res Rev; 2008; 24 Suppl 1():S52-7. PubMed ID: 18395890
[TBL] [Abstract][Full Text] [Related]
20. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
